China Regenerative Medicine International Limited announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was HKD 4.672 million compared to HKD 8.078 million a year ago. Net loss was HKD 15.066 million compared to HKD 36.676 million a year ago. Basic loss per share was HKD 0.01713 compared to HKD 0.04171 a year ago.